View in EDS HTML Full Text PDF Full Text

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.

Saved in:
Bibliographic Details
Title: Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.
Authors: Metz M; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany., Kolkhir P; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany., Altrichter S; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.; Department of Dermatology and Venerology, Kepler University Hospital, Linz, Austria., Siebenhaar F; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Youngblood BA; Allakos Inc., San Carlos, California, USA., Church MK; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany., Maurer M; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.
Source: Allergy [Allergy] 2024 Jan; Vol. 79 (1), pp. 37-51. Date of Electronic Publication: 2023 Aug 22.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37605867
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Metz+M%22">Metz M</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kolkhir+P%22">Kolkhir P</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Altrichter+S%22">Altrichter S</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.; Department of Dermatology and Venerology, Kepler University Hospital, Linz, Austria.<br /><searchLink fieldCode="AU" term="%22Siebenhaar+F%22">Siebenhaar F</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Levi-Schaffer+F%22">Levi-Schaffer F</searchLink>; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Youngblood+BA%22">Youngblood BA</searchLink>; Allakos Inc., San Carlos, California, USA.<br /><searchLink fieldCode="AU" term="%22Church+MK%22">Church MK</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Maurer+M%22">Maurer M</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227804028%22">Allergy</searchLink> [Allergy] 2024 Jan; Vol. 79 (1), pp. 37-51. <i>Date of Electronic Publication: </i>2023 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>Denmark <i>NLM ID: </i>7804028 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1398-9995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201054538%22">01054538 </searchLink><i>NLM ISO Abbreviation: </i>Allergy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37605867
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/all.15850
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 37
    Titles:
      – TitleFull: Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Metz M
      – PersonEntity:
          Name:
            NameFull: Kolkhir P
      – PersonEntity:
          Name:
            NameFull: Altrichter S
      – PersonEntity:
          Name:
            NameFull: Siebenhaar F
      – PersonEntity:
          Name:
            NameFull: Levi-Schaffer F
      – PersonEntity:
          Name:
            NameFull: Youngblood BA
      – PersonEntity:
          Name:
            NameFull: Church MK
      – PersonEntity:
          Name:
            NameFull: Maurer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1398-9995
          Numbering:
            – Type: volume
              Value: 79
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Allergy
              Type: main
ResultId 1